Lindbrook Capital’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $26.8K | Sell |
1,504
-350
| -19% | -$6.24K | ﹤0.01% | 1231 |
|
|
2024
Q4 | $55.2K | Buy |
1,854
+1,213
| +189% | +$36.1K | 0.01% | 776 |
|
|
2024
Q3 | $10K | Sell |
641
-96
| -13% | -$1.5K | ﹤0.01% | 1678 |
|
|
2024
Q2 | $12.6K | Sell |
737
-58
| -7% | -$994 | ﹤0.01% | 1500 |
|
|
2024
Q1 | $12.4K | Buy |
795
+446
| +128% | +$6.97K | ﹤0.01% | 1454 |
|
|
2023
Q4 | $5.21K | Sell |
349
-113
| -24% | -$1.69K | ﹤0.01% | 1861 |
|
|
2023
Q3 | $7.46K | Sell |
462
-76,506
| -99% | -$1.24M | ﹤0.01% | 1560 |
|
|
2023
Q2 | $3.19M | Buy |
76,968
+24,299
| +46% | +$1.01M | 0.34% | 51 |
|
|
2023
Q1 | $3.17M | Buy |
52,669
+2,315
| +5% | +$139K | 0.37% | 49 |
|
|
2022
Q4 | $3.69M | Buy |
50,354
+50,183
| +29,347% | +$3.68M | 0.45% | 49 |
|
|
2022
Q3 | $13K | Buy |
171
+125
| +272% | +$9.5K | ﹤0.01% | 1206 |
|
|
2022
Q2 | $3K | Sell |
46
-5
| -10% | -$326 | ﹤0.01% | 1813 |
|
|
2022
Q1 | $4K | Buy |
51
+41
| +410% | +$3.22K | ﹤0.01% | 1723 |
|
|
2021
Q4 | $1K | Sell |
10
-80
| -89% | -$8K | ﹤0.01% | 1959 |
|
|
2021
Q3 | $10K | Sell |
90
-53
| -37% | -$5.89K | ﹤0.01% | 997 |
|
|
2021
Q2 | $32K | Buy |
143
+13
| +10% | +$2.91K | 0.01% | 620 |
|
|
2021
Q1 | $17K | Buy |
130
+25
| +24% | +$3.27K | ﹤0.01% | 814 |
|
|
2020
Q4 | $18K | Buy |
105
+5
| +5% | +$857 | ﹤0.01% | 722 |
|
|
2020
Q3 | $11K | Buy |
100
+25
| +33% | +$2.75K | ﹤0.01% | 805 |
|
|
2020
Q2 | $4K | Buy |
+75
| New | +$4K | ﹤0.01% | 1188 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1474 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 1417 |
|